Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal RYK Primary Antibody for IHC (p), WB - ABIN392050
Miyashita, Koda, Kitajo, Yamazaki, Takahashi, Kikuchi, Yamashita: Wnt-Ryk signaling mediates axon growth inhibition and limits functional recovery after spinal cord injury. in Journal of neurotrauma 2009
Show all 2 Pubmed References
Human Polyclonal RYK Primary Antibody for IHC (p), WB - ABIN392051
Keeble, Halford, Seaman, Kee, Macheda, Anderson, Stacker, Cooper: The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2006
Mouse (Murine) Polyclonal RYK Primary Antibody for CyTOF, FACS - ABIN4900273
Povinelli, Nemeth: Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. in Stem cells (Dayton, Ohio) 2014
RYK and VANGL2 (show VANGL2 Antibodies) proteins form a complex, whereas RYK also activated RhoA (show RHOA Antibodies), a downstream effector of PCP (show PRCP Antibodies) signaling.
Data suggest that full-length Ryk conveys Wnt5b (show WNT5B Antibodies) signals in a directional manner during gastrulation.
our findings demonstrate that Ryk promotes stem cell-like and tumorigenic features to glioma cells its essential for the maintenance of glioblastoma stem cells
Wnt5A (show WNT5A Antibodies)/Ryk signaling might provide novel therapeutic strategies to prevent capillary leakage in systemic inflammation and septic shock.
results corroborated previous findings of Ryk-mediated Wnt5a (show WNT5A Antibodies) effect, and suggested a role for Ror2 (show ROR2 Antibodies) in the Wnt5a (show WNT5A Antibodies) machinery in glioblastoma
Early treatment with HGF (show HGF Antibodies)/IgG complexes after myocardial ischaemia with reperfusion may rescue tissue through vasoprotection conferred by c-Met and RYK signalling
Ryk-intracellular domain pathway may impair FOXO (show FOXO3 Antibodies) protective activity in mutant polyglutamine neurons, suggesting neurons unable to efficiently maintain function and resist disease from the earliest phases of the pathogenic process in Huntington disease (show HTT Antibodies)
is a candidate wnt5a (show WNT5A Antibodies) receptor.
The Ryk is important for the Wnt-5a (show WNT5A Antibodies)-dependent induction of MMP-2 (show MMP2 Antibodies) and invasive activity in glioma-derived cells and that Ryk might have a novel patho-physiological function in adult cancer invasion.
RYK interacts both physically and functionally with the E3 ubiquitin MIB1. MIB1 is sufficient to activate Wnt (show WNT2 Antibodies)/CTNNB1 (show CTNNB1 Antibodies) signaling and this activity depends on endogenous RYK.
RYK, a catalytically inactive receptor tyrosine kinase (show RET Antibodies), associates with EphB2 (show EPHB2 Antibodies) and EphB3 (show EPHB3 Antibodies) but does not interact with AF-6 (show MLLT4 Antibodies).
Smek1 (show SMEK1 Antibodies) and Smek2 (show SMEK2 Antibodies) (Smek1 (show SMEK1 Antibodies)/2) are key factors in the Ryk signaling pathway
reveal a novel function of Ryk signaling in controlling motor cortex remapping after spinal cord injury in adulthood.
Ryk deficiency in hematopoietic stem cells from fetal liver reduces their quiescence, leading to proliferation-induced apoptosis and decreased self-renewal.
Wnt5a (show WNT5A Antibodies) regulates HSC (show FUT1 Antibodies) quiescence and hematopoietic repopulation through the Ryk receptor and that this process is mediated by suppression of reactive oxygen species.
Ryk inhibits axonal growth in response to Wnt5a (show WNT5A Antibodies).
Ryk is an important mediator of ventral midbrain dopaminergic neuron development.
Ryk regulates Wnt5a (show WNT5A Antibodies) signaling and planar cell polarity by modulating the degradation of Vangl2 (show VANGL2 Antibodies).
RYK and VANGL2 (show VANGL2 Antibodies) proteins form a complex, whereas RYK also activated RhoA (show RHOA Antibodies), a downstream effector of PCP (show BMP1 Antibodies) signaling.
Results identify Ryk as a multi-functional receptor that is able to transduce extrinsic cues into progenitor cells, promote GABAergic neuron formation, and inhibit oligodendrogenesis during ventral embryonic brain development.
The protein encoded by this gene is an atypical member of the family of growth factor receptor protein tyrosine kinases, differing from other members at a number of conserved residues in the activation and nucleotide binding domains. This gene product belongs to a subfamily whose members do not appear to be regulated by phosphorylation in the activation segment. It has been suggested that mediation of biological activity by recruitment of a signaling-competent auxiliary protein may occur through an as yet uncharacterized mechanism. The encoded protein has a leucine-rich extracellular domain with a WIF-type Wnt binding region, a single transmembrane domain, and an intracellular tyrosine kinase domain. This protein is involved in stimulating Wnt signaling pathways such as the regulation of axon pathfinding. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
RYK receptor-like tyrosine kinase
, tyrosine kinase RYK
, ryk receptor-like tyrosine kinase
, receptor-like tyrosine kinase
, tyrosine-protein kinase RYK
, tyrosine kinase-related protein
, tyrosine-protein kinase RYK-like
, JTK5A protein tyrosine kinase
, hydroxyaryl-protein kinase
, growth factor receptor
, kinase VIK
, met-related kinase